Andreas Plückthun
Member of the Board of Directors
chemistry
Molecular Partners
Switzerland
Biography
Prof. Dr. Andreas Plückthun is Full Professor at the Department of Biochemistry at the University of Zurich and a co-founder of Molecular Partners (2004), the German biotechnology company MorphoSys, a leading antibody company (1992), and G7 Therapeutics (2014), a GPCR company, successfully divested to Heptares in 2016. Dr. Plückthun was appointed to the faculty of the University of Zurich as a Full Professor of Biochemistry in 1993. Dr. Plückthun was group leader at the Genzentrum and Max-Planck-Institut für Biochemie in Martinsried, Germany (1985-1993). His pioneering scientific work has made him one of the most highly cited scientists in the protein science field and his work has been honored by a number of international awards. Dr. Plückthun studied chemistry at the University of Heidelberg and received his graduate education at the University of California San Diego, where he obtained a PhD in 1982 in the group of Prof. Edward Dennis. He also worked as a postdoctoral fellow in the Chemistry Department of Harvard University (1982-1985).
Research Interest
chemistry
